[
    {
        "content": "* Hologic announces upcoming put option and notice of redemption of 2.00% convertible senior notes due 2043 Source text for Eikon: Further company coverage:",
        "date": "11142017",
        "name": "Hologic Inc",
        "news_type": "topStory",
        "symbol": "HOLX",
        "title": "BRIEF-Hologic announces upcoming put option "
    },
    {
        "content": "* Hologic announces financial results for fourth quarter of fiscal 2017",
        "date": "11082017",
        "name": "Hologic Inc",
        "news_type": "topStory",
        "symbol": "HOLX",
        "title": "BRIEF-Hologic announces Q4 GAAP earnings per share $0.29 "
    },
    {
        "content": "* Hologic Inc - \u200dreceived 510(k) clearance from FDA for Panther Fusion Paraflu assay\u200b Source text for Eikon: Further company coverage:",
        "date": "10262017",
        "name": "Hologic Inc",
        "news_type": "topStory",
        "symbol": "HOLX",
        "title": "BRIEF-Hologic - \u200dreceived 510(k) clearance from FDA for Panther Fusion Paraflu assay\u200b "
    },
    {
        "content": "* Hologic announces pricing of offering of $350 million aggregate principal amount of 4.375% senior notes due 2025",
        "date": "10042017",
        "name": "Hologic Inc",
        "news_type": "topStory",
        "symbol": "HOLX",
        "title": "BRIEF-Hologic prices offering of $350 mln 4.375 pct senior notes due 2025 "
    },
    {
        "content": "* Hologic announces offering of $350 million of senior notes due 2025",
        "date": "10042017",
        "name": "Hologic Inc",
        "news_type": "normal",
        "symbol": "HOLX",
        "title": "BRIEF-Hologic announces offering of $350 mln of senior notes due 2025 "
    },
    {
        "content": "* Hologic enters into amended and restated five-year secured credit agreement",
        "date": "10042017",
        "name": "Hologic Inc",
        "news_type": "normal",
        "symbol": "HOLX",
        "title": "BRIEF-Hologic enters into amended and restated five-year secured credit agreement "
    },
    {
        "content": "* Hologic receives FDA 510(k) clearance to market SculpSure for non-invasive body contouring (lipolysis) of the submental area (under the chin)",
        "date": "09272017",
        "name": "Hologic Inc",
        "news_type": "topStory",
        "symbol": "HOLX",
        "title": "BRIEF-Hologic receives FDA 510(k) clearance to market SculpSure "
    },
    {
        "content": "* Hologic inc - \u200dU.S. commercial availability of Brevera Breast Biopsy System with Corlumina imaging technology\u200b Source text for Eikon: Further company coverage:",
        "date": "08312017",
        "name": "Hologic Inc",
        "news_type": "topStory",
        "symbol": "HOLX",
        "title": "BRIEF-Hologic updates on commercial availability of Brevera Breast Biopsy System "
    },
    {
        "content": "* Hologic announces financial results for third quarter of fiscal 2017",
        "date": "08022017",
        "name": "Hologic Inc",
        "news_type": "topStory",
        "symbol": "HOLX",
        "title": "BRIEF-Hologic Q3 GAAP earnings per share $0.21 "
    },
    {
        "content": "* Hologic says \u200dupdated Q3 financial results press release to  correct tax impact of certain exclusions in  FY net income per share guidance\u200b - SEC filing",
        "date": "08032017",
        "name": "Hologic Inc",
        "news_type": "topStory",
        "symbol": "HOLX",
        "title": "BRIEF-Hologic updates on FY17 profit outlook "
    },
    {
        "content": "* Obtained a CE mark in Europe for its new Panther Fusion System and Panther Fusion Assays for flu and respiratory testing Source text for Eikon: Further company coverage:",
        "date": "06292017",
        "name": "Hologic Inc",
        "news_type": "topStory",
        "symbol": "HOLX",
        "title": "BRIEF-Hologic obtains CE mark in Europe for Panther Fusion System "
    },
    {
        "content": "* Hologic receives expanded FDA 510(k) clearance to market Cynosure's Sculpsure\u00ae for non-invasive body contouring (lipolysis) of back  inner and outer thighs Source text for Eikon: Further company coverage:",
        "date": "06152017",
        "name": "Hologic Inc",
        "news_type": "topStory",
        "symbol": "HOLX",
        "title": "BRIEF-Hologic receives expanded FDA clearance to market Cynosure's Sculpsure "
    },
    {
        "content": "* FDA approves Hologic's Genius\u2122 3D mammography\u2122 exam as the only mammogram superior for women with dense breasts* Source text for Eikon: Further company coverage:",
        "date": "06072017",
        "name": "Hologic Inc",
        "news_type": "topStory",
        "symbol": "HOLX",
        "title": "BRIEF-Hologic Inc updates on FDA's approval of Genius 3D mammography exam "
    },
    {
        "content": "* Hologic announces financial results for second quarter of fiscal 2017",
        "date": "05102017",
        "name": "Hologic Inc",
        "news_type": "topStory",
        "symbol": "HOLX",
        "title": "BRIEF-Hologic announces Q2 revenue $715.4 million "
    },
    {
        "content": "April 12 Medical device maker Hologic Inc has been hit with a lawsuit alleging its product for treating heavy menstrual bleeding infringes patented technology developed by start-up Minerva Surgical Inc  court papers show.",
        "date": "04122017",
        "name": "Hologic Inc",
        "news_type": "normal",
        "symbol": "HOLX",
        "title": "Hologic faces U.S. patent lawsuit over menstrual bleeding device "
    },
    {
        "content": "* Hologic delivers notice that holders of 2.00pct convertible exchange senior notes due 2042 are eligible to convert Source text for Eikon: Further company coverage:",
        "date": "04032017",
        "name": "Hologic Inc",
        "news_type": "topStory",
        "symbol": "HOLX",
        "title": "BRIEF-Hologic delivers notice that holders of 2.00pct convertible exchange senior notes due 2042 are eligible to convert "
    },
    {
        "content": "* Cynosure - Compensation committee established $13 million cash pool from making severance payments for persons without employment agreements relating to Hologic deal  Source: (http://bit.ly/2lL68PF) Further company coverage:",
        "date": "02222017",
        "name": "Hologic Inc",
        "news_type": "topStory",
        "symbol": "HOLX",
        "title": "BRIEF-Cynosure says Compensation Committee established $13 mln cash pool from making severance payments related to Hologic deal "
    },
    {
        "content": "* FDA grants PMA approval for Hologic's Aptima hepatitis C Quant DX Assay  Source text for Eikon:  Further company coverage:",
        "date": "02152017",
        "name": "Hologic Inc",
        "news_type": "topStory",
        "symbol": "HOLX",
        "title": "BRIEF-FDA grants PMA approval for Hologic's Aptima hepatitis C Quant DX Assay "
    },
    {
        "content": "* Hologic - upon termination of deal  under specified circumstances Cynosure has agreed to pay co termination fee of about $57.7 million   Source text - http://bit.ly/2kuOElN Further company coverage:",
        "date": "02142017",
        "name": "Hologic Inc",
        "news_type": "topStory",
        "symbol": "HOLX",
        "title": "BRIEF-Cynosure agrees to termination fee of $57.7 mln for Hologic deal "
    },
    {
        "content": "Hologic Inc said on Tuesday it would acquire medical aesthetics company Cynosure Inc for $1.65 billion as it looks to capitalize on an increase in medical procedures that are not traditionally reimbursed.",
        "date": "02142017",
        "name": "Hologic Inc",
        "news_type": "normal",
        "symbol": "HOLX",
        "title": "Hologic to buy Cynosure to expand into medical aesthetics "
    },
    {
        "content": "* Cynosure shares up 28 pct; Hologic down 3.6 pct   (Adds analyst comments  details)",
        "date": "02142017",
        "name": "Hologic Inc",
        "news_type": "normal",
        "symbol": "HOLX",
        "title": "UPDATE 3-Hologic to buy Cynosure to expand into medical aesthetics "
    },
    {
        "content": "* Hologic to acquire Cynosure  leader in medical aesthetics systems and technologies  in all-cash tender offer that combines two complementary businesses",
        "date": "02142017",
        "name": "Hologic Inc",
        "news_type": "normal",
        "symbol": "HOLX",
        "title": "BRIEF-Hologic to acquire Cynosure for $1.65 bln "
    },
    {
        "content": "Feb 14 Hologic Inc said on Tuesday that it would acquire medical aesthetics company Cynosure Inc  for $1.65 billion.",
        "date": "02142017",
        "name": "Hologic Inc",
        "news_type": "normal",
        "symbol": "HOLX",
        "title": "Hologic to buy Cynosure for $1.65 bln "
    },
    {
        "content": "* Hologic launches next-generation Novasure advanced global endometrial ablation system for the treatment of abnormal uterine bleeding  Source text for Eikon:  Further company coverage:",
        "date": "02022017",
        "name": "Hologic Inc",
        "news_type": "topStory",
        "symbol": "HOLX",
        "title": "BRIEF-Hologic launches next-generation Novasure advanced global endometrial ablation system for the treatment of abnormal uterine bleeding "
    },
    {
        "content": "* Qtrly revenue of $734.4 million increased 5.6%  or 6.3% in constant currency terms",
        "date": "02012017",
        "name": "Hologic Inc",
        "news_type": "topStory",
        "symbol": "HOLX",
        "title": "BRIEF-Hologic reports Q1 GAAP EPS of $0.30 "
    },
    {
        "content": "* Hologic announces financial results for first quarter of fiscal 2017",
        "date": "02012017",
        "name": "Hologic Inc",
        "news_type": "normal",
        "symbol": "HOLX",
        "title": "BRIEF-Hologic Q1 non-gaap EPS $0.52 "
    },
    {
        "content": "* Hologic completes divestiture of blood screening business  Source text for Eikon:  Further company coverage:",
        "date": "01312017",
        "name": "Hologic Inc",
        "news_type": "topStory",
        "symbol": "HOLX",
        "title": "BRIEF-Hologic completes divestiture of blood screening business "
    },
    {
        "content": "Spain's Grifols SA   which develops plasma protein therapies  said it would buy U.S. medical device maker Hologic Inc's  interest in their blood screening joint venture for $1.85 billion in cash.",
        "date": "12142016",
        "name": "Hologic Inc",
        "news_type": "topStory",
        "symbol": "HOLX",
        "title": "Grifols to buy Hologic's stake in blood screening JV for $1.85 billion "
    },
    {
        "content": "Nov 28 Hanwha Ace Special Purpose Acquisition 1st Co Ltd :",
        "date": "11282016",
        "name": "Hologic Inc",
        "news_type": "topStory",
        "symbol": "HOLX",
        "title": "BRIEF-Hologic buys 5.8 pct stake in Hanwha Ace Special Purpose Acquisition 1st "
    },
    {
        "content": "* Hologic announces upcoming put option and notice of redemption of 2.00% convertible exchange senior notes due 2037  Source text for Eikon:  Further company coverage:",
        "date": "11092016",
        "name": "Hologic Inc",
        "news_type": "topStory",
        "symbol": "HOLX",
        "title": "BRIEF-Hologic announces notice of redemption of senior notes due 2037 "
    },
    {
        "content": "* Hologic inc -  for fiscal 2017  hologic expects revenues of $2.94 to $2.98 billion",
        "date": "11022016",
        "name": "Hologic Inc",
        "news_type": "topStory",
        "symbol": "HOLX",
        "title": "BRIEF-Hologic reports Q4 gaap earnings per share $0.33 "
    },
    {
        "content": "* FDA expands emergency use authorization for Hologic's Aptima Zika virus assay to include use with urine samples",
        "date": "09082016",
        "name": "Hologic Inc",
        "news_type": "topStory",
        "symbol": "HOLX",
        "title": "BRIEF-FDA expands emergency use authorization for Hologic's Aptima Zika virus assay "
    },
    {
        "content": "Aug 9 U.S. Department of Health and Human Services:",
        "date": "08092016",
        "name": "Hologic Inc",
        "news_type": "topStory",
        "symbol": "HOLX",
        "title": "BRIEF-U.S. HHS awards $4.1 mln to Hologic to develop better Zika blood screening test "
    },
    {
        "content": "* Bovie medical announces sales channel partnership agreement with hologic for J-Plasma\u007f",
        "date": "07212016",
        "name": "Hologic Inc",
        "news_type": "topStory",
        "symbol": "HOLX",
        "title": "BRIEF-Bovie Medical announces deal with Hologic Inc "
    },
    {
        "content": "* FDA has approved use of Procleix Zika virus blood screening assay on Procleix panther system under agency's investigational new drug study protocol",
        "date": "06202016",
        "name": "Hologic Inc",
        "news_type": "topStory",
        "symbol": "HOLX",
        "title": "BRIEF-Hologic  Grifols say FDA approves Zika diagnostic test "
    },
    {
        "content": "June 17 Hologic Inc won emergency U.S. authorization to sell its Zika test  expanding the number of public and private labs that can test for the virus as health officials brace for a rise this summer in the number of infections.",
        "date": "06172016",
        "name": "Hologic Inc",
        "news_type": "normal",
        "symbol": "HOLX",
        "title": "Hologic wins emergency U.S. authorization for Zika test "
    },
    {
        "content": "* Carl Icahn holdings cited is Icahn's shared share stake in the respective companies  Source text for quarter ended March 31  2016:  (http://1.usa.gov/1OxDwCP) Source text for quarter ended Dec 31  2015:  (http://1.usa.gov/1TgSRoa)     (Bengaluru Newsroom; +1 646 223 8780; )",
        "date": "05162016",
        "name": "Hologic Inc",
        "news_type": "topStory",
        "symbol": "HOLX",
        "title": "BRIEF-Carl Icahn  dissolves shared share stake in Hologic Inc "
    },
    {
        "content": "The father of a former investment banker at Perella Weinberg Partners and JPMorgan Chase & Co was sentenced on Wednesday to a year of home confinement and three more years of probation  for trading securities ahead of healthcare mergers based on tips from his son.",
        "date": "05042016",
        "name": "Hologic Inc",
        "news_type": "normal",
        "symbol": "HOLX",
        "title": "Father of ex-investment banker avoids prison for insider trading "
    },
    {
        "content": "* Q2 earnings per share view $0.46 -- Thomson Reuters I/B/E/S",
        "date": "04272016",
        "name": "Hologic Inc",
        "news_type": "topStory",
        "symbol": "HOLX",
        "title": "BRIEF-Hologic Q2 non-GAAP earnings per share $0.47 "
    },
    {
        "content": "* Carl icahn reports 3.61 pct stake in hologic as of april 13 - sec filing",
        "date": "04132016",
        "name": "Hologic Inc",
        "news_type": "topStory",
        "symbol": "HOLX",
        "title": "BRIEF-Carl Icahn cuts stake in Hologic to 3.61 pct from 5.58 pct "
    },
    {
        "content": "* Carl Icahn reports reduced stake of 5.58 percent in Hologic Inc as of April 4  2016 - SEC filing",
        "date": "04042016",
        "name": "Hologic Inc",
        "news_type": "topStory",
        "symbol": "HOLX",
        "title": "BRIEF-Carl Icahn cuts stake in Hologic to 5.58 pct "
    },
    {
        "content": "* Carl Icahn reports 6.75 pct stake in hologic Inc -Sec Filing",
        "date": "03292016",
        "name": "Hologic Inc",
        "news_type": "topStory",
        "symbol": "HOLX",
        "title": "BRIEF-Carl Icahn had earlier reported a stake of 7.83 percent in Hologic Inc "
    },
    {
        "content": "NEW YORK  Aug 12 The father of a former investment banker at Perella Weinberg Partners pleaded guilty on Wednesday to a charge that he illegally traded securities ahead of healthcare mergers based on information supplied by his son.",
        "date": "08122015",
        "name": "Hologic Inc",
        "news_type": "normal",
        "symbol": "HOLX",
        "title": "Ex-Perella Weinberg banker's father pleads guilty to insider trading "
    }
]